TW387883B - Intermediates for the preparation of 2-imidazolin-5-ones - Google Patents
Intermediates for the preparation of 2-imidazolin-5-ones Download PDFInfo
- Publication number
- TW387883B TW387883B TW86110426A TW86110426A TW387883B TW 387883 B TW387883 B TW 387883B TW 86110426 A TW86110426 A TW 86110426A TW 86110426 A TW86110426 A TW 86110426A TW 387883 B TW387883 B TW 387883B
- Authority
- TW
- Taiwan
- Prior art keywords
- patent application
- compound
- group
- formula
- item
- Prior art date
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
A7 B7 五、發明説明( 本發明係關於可用作製備殺眞菌用途之2 -二氫咪唑- 5· 酮之中間物的新穎產物。本發明亦關於製備此等新穎產物 之方法,及由此等新穎中間物獲得之2 -二氳咪嗅-5-網之 方法。 2-二氫咪唑-5-酮作殺眞菌用途爲已知,特別是參見歐 洲專利申請案丑?551,048號,£? 599,749號及£? 629,616號, 及參見國際申請案W0 93/24467號。 本發明之一目的,係提出製備此等2 -二氫咪唑-5 -酮之新 穎中間物。 本發明之另一目的係提出一種.獲得安全性增進之殺眞菌 2·二氫咪唑-5-酮之新穎途徑》 本發明於是提供通式(I)之2 -二氫咪也-5-酮, .... 「 (請先閲讀背面之注項再本頁) 裝. 、trA7 B7 V. Description of the invention (The present invention relates to novel products which can be used as intermediates of 2-dihydroimidazol-5 · one for the preparation of bactericidal fungi. The present invention also relates to methods for preparing these novel products, and from this And other novel intermediates to obtain 2-dihydropyridine-5-net. 2-dihydroimidazol-5-one is known for its fungicidal activity, especially see European Patent Application No. 551,048 No. 599,749 and No. 629,616, and see International Application No. WO 93/24467. One object of the present invention is to propose novel intermediates for the preparation of these 2-dihydroimidazol-5-ones. Another object is to propose a novel way to obtain the bactericidal 2-dihydroimidazol-5-one with improved safety. The present invention thus provides 2-dihydroimid-5-one of the general formula (I). ... "(Please read the note on the back before this page)
(I) -線 經 中 央 梂 準 局 ψ' 合 作 社 式中, -R1爲C1-C3烷基或苯基, -R2爲選自苯基或吡啶基中之芳基,視需要經選自鹵原 子 '硝基或氰基中之1至3個基團取代,及C1_C3烷基或CL· C3烷氧基; 但是,4 -乙基-4-苯基_2_硫四氨n塞峻除外。 本發明之主體亦爲式(I)化合物之成鹽形式及立體異構 物。特定言之’本發明之主體爲由具不對稱碳而來之光學 -4-本紙張尺度適用中國國家糅準(CNS ) A4规格(2丨0X297公釐) 五、發明説明(2 ) A7 B7 經濟部中央標準局貝工消費合作社印装 異構物,最特別的是,若R1&R2基不同,則由接幻及以 之不對稱碳而來之光學異構物。此等光學異構物爲光學純 度化合物或富含一種鏡像異構物之化合物。於下文,富含 預定鏡像異構物之表現光學活性化合物,需知稱作含至少 80%(較佳至少90%)此鏡像異構物之化合物。所有此等化 合物咸認均包含於上述式(1)中。 . 式(I)化合物中,較佳者如下, •R1爲C1-C3烷基, -R2表不苯基,視需要經鹵原子、氰基或硝基取代,或爲 甲基或甲氧基。 _ 更特定言之式(I )化合物中,以R2爲苯基及R1爲曱基者 較佳。 根據本發明極有利之變換,式(〗)化合物,式中: -R1爲甲基,及 -R2爲苯基, 乃就接R1及R2之不對稱碳而爲鏡像異構物。 於本文.中,後述化學式中之所有基,及通式(〗)中已定 義之基,除非另外指明,否則均保留相同意義。於本説明 書’包含隨後之申請專利範圍中,烷基及部分基可爲直鏈 或分支鏈。 茲敘述一種製備式(I)化合物之模式。此製備模式乃就 接R1及R2之基之碳爲消旋之化合物而言。但是,熟諳此 項技藝者會用此等相同反應,以獲得對接R1&R2之破爲 鏡像異構物之式(1)化合物。此理由在於下述反應全然具 -5- (請先閲讀背面之注意事項再0¾本頁) -裝· 訂 -線 ^7. 經 央 標 牟 r 合 作 社 裝 五、發明説明(3) A7 B7 立體選擇性,即於此相同碳之絕對組態中,不會導致任何 變化。 式(I)化合物之獲得,可使式(II)化合物與二硫化碳,視 需要於溶劑或溶劑混合液中,視需要於鹼之存在下,οι 至+ 5〇 ec溫度,根據下圖進行反應, 0 (II) 驗 CS, 0 ,NFh-〇-SH % m(I)-In the formula of the Central Bureau of Standards and ψ 'Cooperative, -R1 is a C1-C3 alkyl or phenyl group, and -R2 is an aryl group selected from phenyl or pyridyl, and if necessary, selected from a halogen atom 'One to three groups of nitro or cyano are substituted, and C1-C3 alkyl or CL · C3 alkoxy; except for 4-ethyl-4-phenyl_2-thiotetraamine. The subject matter of the invention is also the salt-formed form and stereoisomers of the compound of formula (I). In particular, 'the main body of the present invention is optical from asymmetric carbon -4- The paper size is applicable to China National Standard (CNS) A4 specification (2 丨 0X297 mm) 5. Description of the invention (2) A7 B7 The isomers are printed by the Shell Standard Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. The most special is that if the R1 & R2 groups are different, the optical isomers come from the asymmetric carbon. These optical isomers are optically pure compounds or compounds enriched in a mirror image isomer. In the following, the optically active compound that is rich in a predetermined image isomer is referred to as a compound containing at least 80% (preferably at least 90%) of this image isomer. All of these compounds are included in the above formula (1). Among the compounds of formula (I), the following are preferred: • R1 is a C1-C3 alkyl group, and -R2 represents a phenyl group, optionally substituted with a halogen atom, a cyano group, or a nitro group, or a methyl group or a methoxy group . _ More specifically, among the compounds of formula (I), R2 is a phenyl group and R1 is a fluorenyl group. According to a very advantageous transformation of the present invention, the compound of formula () is: -R1 is a methyl group, and -R2 is a phenyl group, which are mirror image isomers of the asymmetric carbons connected to R1 and R2. In this article, all the radicals in the chemical formulas described below, and the radicals defined in the general formula (〗), have the same meaning unless otherwise specified. In the scope of this specification, including subsequent patent applications, alkyl groups and partial groups may be straight or branched. A mode for preparing the compound of formula (I) is described. This mode of preparation is for compounds in which the carbon attached to the base of R1 and R2 is racemic. However, those skilled in the art will use these same reactions to obtain the compound of formula (1) which docks R1 & R2 as a mirror image isomer. The reason for this is that the following reactions are completely -5- (Please read the notes on the back before you go to this page)-Binding, binding-thread ^ 7. Jingyang Biaomu Cooperative Cooperative V. Description of the invention (3) A7 B7 Selectivity, that is, no change in this absolute configuration of the same carbon. The compound of formula (I) can be obtained by reacting the compound of formula (II) with carbon disulfide in a solvent or a solvent mixture as needed, and in the presence of a base at a temperature of οι to +50 ec, according to the following figure 0 (II) CS, 0, NFh-〇-SH% m
(I) 式中,R3爲胺基或羥基,或具t至6個(較佳至3個)碳 原子之烷氧基,或視需要經_原子取代之苯甲氧基。 視需要使用之鹼可爲無機鹼,如鹼金屬或鹼土金屬氫氧 化物或破酸鹽,或有機鹼如一級,二級或三級胺。鹼/化 合物II之比率(以莫耳數表示)爲0.05至1_2,較佳0.1至i。 於此圖中,式(III)化合物可單離成中間物,若用鹼,則 成鹽形式。 可使用之溶劑爲水、醚類、環狀醚類、烷基酯類,偶極 性溶劑類如6·腈,具1至4個碳原予之醇類、芳族溶劑類, 較佳爲甲苯、二氣甲燒或氣仿,及二硫化碳。可使用之容 劑混合液爲一種以上之醇類與一種以上之上述溶劑類之混 合液。 若R3爲經基,較佳以水作溶劑β 若R3不爲羥基,較佳以醇/水之混合液作溶劑。 -6- 本紙張尺度適用中國國家梯準(CNS )八姑^格(2丨〇><297公着 (請先閱讀背面之注意事項再Jr,J€本頁) 裝‘ 訂 銼濟部中央揉半局貝工消费合作社印製 A7 ----B7 五、發明説明(4 ) 式(III)化合物單離時,可於25 ,c至所用溶劑之回流溫度_ 下’直接加熱轉化成化合物(J。中間化合物(111)之轉化成 化合物(I ),可以強酸爲無機酸如鹽酸或硫酸,或有機酸 如三氟乙酸,處理進行之。 此過程較佳於無鹼存在或20至40T:溫度下進行。於此過 程’式(III)化合物未予單離。 · 自化合物(Π)起始製備化合物(J)之另一程序模式,記述 於 A.C. Davis 及 A.J., Levy 著化學會誌(J. Chem. Soc.) 2419-25 頁(1951年)或κ· Hofmann等著美國化學學會會誌(j. Am. Chem. Soc ),74 卷,470 〜47 6 頁(1952 年)。 式(II)(式中,R3爲烷氧基〕之α -胺基酯之獲得,可根 據 M. Brenner 及 W. Huber 著瑞士化學學報(Helv Ch.(I) In the formula, R3 is an amine group or a hydroxyl group, or an alkoxy group having t to 6 (preferably to 3) carbon atoms, or a benzyloxy group substituted with an _ atom if necessary. The base used as required may be an inorganic base such as an alkali metal or alkaline earth metal hydroxide or a salt of a broken acid, or an organic base such as a primary, secondary or tertiary amine. The base / compound II ratio (expressed in moles) is from 0.05 to 1_2, preferably from 0.1 to i. In this figure, the compound of formula (III) can be isolated into an intermediate, and if a base is used, it can be in the form of a salt. The solvents that can be used are water, ethers, cyclic ethers, alkyl esters, dipolar solvents such as 6 · nitrile, alcohols and aromatic solvents with 1 to 4 carbon atoms, preferably toluene , Two gas methyl or gas imitation, and carbon disulfide. The solvent mixture that can be used is a mixture of one or more alcohols and one or more of the above solvents. If R3 is a base, water is preferably used as the solvent β. If R3 is not a hydroxyl group, an alcohol / water mixed solution is preferably used as the solvent. -6- This paper size is applicable to the Chinese National Standards of Standards (CNS) Bagu ^ grid (2 丨 〇 > < 297) (Please read the precautions on the back before Jr, J € this page) Printed by the central and central bureau of Shellfish Consumer Cooperative Co., Ltd. A7 ---- B7 V. Description of the invention (4) When the compound of formula (III) is isolated, it can be directly heated and converted at 25, c to the reflux temperature of the solvent used. The compound (J. intermediate compound (111) is converted into compound (I), which can be treated by treating a strong acid with an inorganic acid such as hydrochloric acid or sulfuric acid, or an organic acid such as trifluoroacetic acid. This process is preferred to the absence of an alkali or 20 To 40T: at temperature. In this process, the compound of formula (III) was not isolated. · Another procedure for preparing compound (J) from compound (Π) is described in AC Davis and AJ, Levy Journal of the Society (J. Chem. Soc.) 2419-25 (1951) or κ · Hofmann waiting for the Journal of the American Chemical Society (j. Am. Chem. Soc), Volume 74, 470 ~ 47 6 pages (1952) ). The α-amino ester of formula (II) (wherein R3 is an alkoxy group) can be obtained according to M. Brenner and W. Huber. Chemistry and Technology (Helv Ch.
Acta)( 1953年),36卷,1109〜1115頁記述之類似程序,使 對應之α ·胺基酸進行酯化反應爲之。 式(11)(式中,R3爲胺基)之胺基醯胺之獲得,可根據 J. A. Garbarino 著義大利化學紀事(Ann. chiMca ItaL ),59 卷 ,841〜849頁( 1969年)之記述,自胺基酯以氨之作用爲之。. α -胺基酸係根據本身已知之反應及方法製備之。 若式(II)化合物爲胺基酯鏡像異構物,特定由下述獲得 之: 一根據 R. S. Atkinson 等著四面體(Tetrahedron ),1992 年, 48期,7713-30頁之記述,前非對稱(prochiral)化合物進行 非鏡像選擇性胺化反應,接著,非對稱偶合經脱保護基反 應,或 本纸張尺度適用中國國家橾準(CNS ) A4规格(210X297公釐) ------^--;---裝-- * \1·: (請先閲讀背面之注意事項再f為本X) 訂 五、發明説明(5) -根據Y. Sugi及S. Mitsui著曰本化孚學會通報(BullActa (1953), Vol. 36, pp. 1109 ~ 1115, a similar procedure is described in which the corresponding α-amino acid is subjected to an esterification reaction. The obtaining of aminoamidoamine of formula (11) (wherein R3 is an amine group) can be described according to JA Garbarino's Ann. ChiMca ItaL, Volume 59, pages 841 ~ 849 (1969) From the role of amino esters to ammonia. α-Amino acids are prepared according to reactions and methods known per se. If the compound of formula (II) is an amine ester mirror isomer, it is specifically obtained from the following:-According to RS Atkinson et al., Tetrahedron, 1992, No. 48, 7713-30, formerly asymmetric (Prochiral) compound undergoes non-mirror selective amination reaction, and then, asymmetric coupling via deprotection reaction, or this paper size applies China National Standard (CNS) A4 specification (210X297 mm) ------ ^-; --- install-* \ 1 ·: (Please read the precautions on the back before f is X) Order V. Description of the Invention (5)-According to Y. Sugi and S. Mitsui Bulletin of the Society
Chem,Soc. Japan),1969 年,辽期 ’ 2984-89 頁之記述,對 應之消旋混合物與非對稱化合物解離,或者 -根據D. J. Cram等著美國化學學會會誌,1961年,监_期 ,2183-89頁之記述,非對稱胺基酸進行酯化反應, 右式(II)化合物爲胺基酿胺鏡像異構物’可根據H. Dahii 等著瑞士化學學報,53卷,1370〜;1378頁(1970年)之記述, 自非對稱胺基酯起,始,或由對應之消旋混合物解離,而獲 得之。 式(I )之2 -硫四氫噻唑-5-酮係用以製備殺眞菌之式(ιν)2 _ 二氫咪唑-5·酮,Chem, Soc. Japan), 1969, "Liao period" pages 2984-89, corresponding to the dissociation of racemic mixtures from asymmetric compounds, or-according to DJ Cram et al. Journal of the American Chemical Society, 1961, period On pages 2183-89, the asymmetric amino acid undergoes esterification, and the compound of the right formula (II) is an amine-based amine mirror isomer. 'According to H. Dahii et al., Swiss Chemical Journal, Vol. 53, 1370 ~ ; The description on page 1378 (1970) is obtained starting from the asymmetric amino ester, or by dissociation from the corresponding racemic mixture. 2-thiotetrahydrothiazol-5-one of formula (I) is used to prepare bactericidal formula (ιν) 2_dihydroimidazole-5 · one,
R4 (IV) 式中, -M表TF氧或硫原子; -R30表示直鏈或分支鏈之含1至6個碳原子之娱;基,或直 鏈或分支鏈之含1至6個碳原子之_烷基; -R4表示息原子或酿基; -R5表示選自下列之芳基或雜芳基:苯基、莕基、咄啶基 、嘧啶基、嗒哜基、吡呼基、嘧吩基、苯并嘧吩基、呋 喃基、苯幷吱喃基、咬p林基、異峻〃林基或亞甲二氧苯基 此等基囷各視需要經1至7個基,較佳爲i至3個選自R51 -8 - 本纸張纽逍用中“家栳準(CNS )八4胁(210X297公釐)—'—~:-------- 五、發明説明(6 A7 B7 經 部 央 揉 準 局 貝 合 作 社 印 % 定義之可相同或不同之基團取代,如下述; -R51表示: -鹵原子或 -直鏈或分支鏈之含1至6個碳原子之烷基、卣烷基 '烷 氧基、自烷氧基、烷硫基、由烷硫基或烷磺醯基,或 -含3至6個碳原子之環烷基、由環烷基、烯氧基、炔氧 基、晞硫基或炔硫基,或 -梢基或氰基,或 -胺基,視需要經丨至6個碳原子之烷基或醯基或2至6個 碳原子之烷氧羰基進行單取代或二取代; 以及此等化合物及其立體異構物之農業上可接受之成鹽 形成’特定言之,若R1及R2不同,則爲由接R1&R2基之 不對稱碳存在而來之光學異構物。 兹記述根據以消旋系列或鏡像異構物系列之方法,由本 發明主體式(1)2-硫四氫嘧唑-5-酮起始,製備殺眞菌之式 (IV)化合物。 式(I )化合物與式(V)化合物通常於溶劑中及+ 2〇 *c至 +100 °C(較佳40至80。(:)溫度下,根據下圖進行反應,R4 (IV) where -M represents a TF oxygen or sulfur atom; -R30 represents a straight or branched chain containing 1 to 6 carbon atoms; a radical, or a straight or branched chain containing 1 to 6 carbons _Alkyl of the atom; -R4 represents an interest atom or an aryl group; -R5 represents an aryl or heteroaryl group selected from the group consisting of phenyl, fluorenyl, amidinyl, pyrimidinyl, daphnyl, pyrhyl, Pyrimidyl, benzopyrimyl, furanyl, phenylsulfanyl, p-ringyl, isophenyl, or methylenedioxyphenyl groups, each of which may be carried through from 1 to 7 groups, as required, Preferably, i to 3 are selected from R51 -8-"Paper Standard (CNS) 8 4 (210X297 mm)" in this paper for New Year's Eve —'— ~: -------- V. Description of the invention (6 A7 B7) The same or different groups may be substituted as defined by the Ministry of Justice and the Central Bureau of Cooperatives, as shown below;-R51 means:-halogen atom or-straight or branched chain containing 1 to 6 Carbon alkyl, alkyl, alkoxy, alkoxy, alkylthio, alkylthio or alkylsulfonyl, or-cycloalkyl containing 3 to 6 carbon atoms, cycloalkane , Alkenyloxy, alkynyloxy, sulfanyl or alkynylthio, or -terminal or cyano , Or-amine group, if necessary, mono- or di-substituted by an alkyl or fluorenyl group of 6 to 6 carbon atoms or an alkoxycarbonyl group of 2 to 6 carbon atoms; and the compounds and their stereoisomers "Agriculturally acceptable salt formation" In particular, if R1 and R2 are different, they are optical isomers derived from the presence of asymmetric carbons connected to the R1 & R2 group. The description is based on the racemic series or mirror image. The structure series method starts from the main formula (1) 2-thiotetrahydropyrazol-5-one of the present invention to prepare a fungicidal compound of formula (IV). The compound of formula (I) and the compound of formula (V) are generally The reaction is carried out in a solvent at a temperature of + 20 * c to +100 ° C (preferably 40 to 80. (:)) according to the following figure.
k (V) h2s (VI) n 可用之溶劑例如:二哼烷、偶極性質子惰性溶劑,特定 言之,N -甲基吡咯酮' 二甲基甲醯胺、二甲亞砜或乙腈, -9- 本紙張A度遑用中國國家梯準(CNS ) A4规格(210X297公釐) 趣濟部中央梯隼局貞工消賢合作杜印製 A7 B7 五、發明説明(7 ) 包括1至4個碳原子之醇(更特定爲甲醇)’芳族溶劑(更特-定爲V»比淀或單氣苯)。 此反應進行較佳使用之催化劑選自第三胺如三乙胺或三 丁胺,或此胺之有機鹽,如三丁胺乙酸鹽。此催化劑通常 以催化劑/化合物(I )之比率(以莫耳數表示)爲0.05至1 (較 佳0.1至0.5)存在。如此則獲得增進之純度。· 式(VI)硫乙内醯脲根據專利申請案EP 551,048號、EP 599,749號及EP 629,616號中之一所述之方法,轉化成式(IV )2-二氫咪唑-5-酮。 下述實例僅用以闡述本發唞主體之化合物及製備方法, 絕不由此限制本發明之範圍。所闡述衍生之構造以至少一 種下述光譜技術建立:質子NMR光譜測定法、碳13NMR光 譜測定法、紅外線光譜測定法及質量光譜測定法,以及測 定旋光度之習用方法。 實例1 :自胺基醯胺製備(4S)_4-曱基-4-苯基-2-硫四氫嘍 唑-5-嗣 3.26克(20毫吴耳)(2S)- 2 -胺基-2-苯基丙酿胺,6毫升 (100耄莫耳)二硫化碳及4毫升乙骑輸入設置機械授拌器之 50毫升圓底燒瓶中。此不勻介質於2〇eC持續攪拌20小時。 過量之二硫化碳及乙腈經眞空蒸餾後,予以純化及過遽, 獲得3.70克(4S)-4-甲基-4-苯基-2-硫四氫P塞咬-5-酮,爲 白色固體,熔點104 eC,產率相當於83 %。 實.例纟:自胺基酯製備(4S)_4 -甲基-4-苯基-2-硫四氫嘍唑 -5-酮 -10- 本紙張尺度適用中國困家樣準(CNS ) A4規格(210X297公釐) -'~~ --— (請先閲讀背面之注$項再0,>v本頁) >裝_ 訂_k (V) h2s (VI) n Solvents that can be used are, for example, dihenane, dipolar aprotic solvents, in particular, N-methylpyrrolidone 'dimethylformamide, dimethylsulfoxide or acetonitrile, -9- This paper uses Chinese National Ladder Standard (CNS) A4 size (210X297mm) for this paper. Duo printed A7 B7 cooperation with the Central Government Bureau of the Ministry of Economic Affairs. 5. Description of the invention (7) Including 1 to Alcohols (more specifically methanol) with 4 carbon atoms' aromatic solvents (more specifically-designated as V »bito or monogas benzene). The catalyst preferably used for this reaction is selected from a third amine such as triethylamine or tributylamine, or an organic salt of this amine such as tributylamine acetate. This catalyst is usually present at a catalyst / compound (I) ratio (expressed in moles) of 0.05 to 1 (preferably 0.1 to 0.5). In this way, an increased purity is obtained. Thiothelide urea of formula (VI) is converted to 2-dihydroimidazol-5-one of formula (IV) according to the method described in one of the patent applications EP 551,048, EP 599,749 and EP 629,616. The following examples are only used to illustrate the compounds and preparation methods of the subject of the present invention, and in no way limit the scope of the present invention. The derived structures described are established by at least one of the following spectroscopic techniques: proton NMR spectrometry, carbon 13 NMR spectrometry, infrared spectrometry, and mass spectrometry, and customary methods for measuring optical rotation. Example 1: Preparation of (4S) _4-fluorenyl-4-phenyl-2-thiotetrahydrooxazole-5-fluorene from amidoamine 3.26 g (20 milliwatts) of (2S) -2-amino- 2-Phenylpropanamine, 6 ml (100 mol) carbon disulfide and 4 ml acetochloride were put into a 50 ml round bottom flask equipped with a mechanical stirrer. This heterogeneous medium was continuously stirred at 20eC for 20 hours. Excess carbon disulfide and acetonitrile were subjected to vacuum distillation, and then purified and purified to obtain 3.70 g of (4S) -4-methyl-4-phenyl-2-thiotetrahydro-P-sep-5-one as a white solid. Melting point is 104 eC, yield is equivalent to 83%. Real Example 纟: Preparation of (4S) _4-methyl-4-phenyl-2-thiotetrahydrooxazole-5-one-10- from amine esters This paper is applicable to Chinese standards (CNS) A4 Specifications (210X297mm)-'~~ --- (Please read the note on the back, then 0, > v this page) > equipment_ order_
-線 C 387883 A? ____ B7 五、發明説明(8 ) 2克(11.1¾旲耳)(2S)-2-胺基-2-苯基丙酸甲醋,ι5毫升 四氫呋喃,1.82毫升(13毫莫耳)三乙胺及〇78毫升(13毫 莫耳)二硫化碳輸入設置磁力攪拌器之25毫升試管中。經 密封後,試管保持於45 °C,均勾介質於此溫度持續攪拌4 小時。 經冷却及純化後’獲得2克(4S)_4-甲基_4_苯基·2_硫四 氫嘧唑-5 -酮,爲白色粉末,即產率80 〇/〇。 實,H :製備(4S)_.4·甲基-4-苯基-.1-苯胺基-2-硫乙内醯 脲 893毫克(4笔莫耳)(4S)- 4 -甲基-4-苯基-2-硫四氫u塞峻_ 5-酮,8毫升乙腈及1〇〇毫升(〇.4毫莫耳)三丁胺輸入設置 磁力授掉器之25毫升圓底燒瓶中。混合物加熱至,然 後,520毫克(4.8毫莫耳)苯基肼於4.5毫升乙腈之溶液加入 進行2小時。反應介質於80 °C加熱6小時。經冷却後,減壓 蒸餾移除乙腈。經純化後,獲得975毫克(4S)-4-甲基-4·苯 基-1-苯胺基-2-硫乙内酿脲,爲白色固體,溶點167。0, 以HPLC測定純度爲100 %,即產率爲82 %。 實例4 :自(2S)-2 -胺基-2 -苯基丙酸製備(4S)-4 -甲基-4-本基-2 ·硫四氨p塞岭·5-嗣 11克(1〇·2莫耳)(2S)- 2 -胺基-2 -苯基丙酸(或含15重量% 胺基酸於固體NaCl之混合物形式),10毫升N -曱基吡咯酮 ,0.8克(2.ΗΓ2莫耳)氫氧化鈉丸塊,接著1.8毫升(3.ΗΓ2莫 耳)二硫化碳,依序輸入設置磁力攪拌器之50毫升圓底燒 瓶中。經密封後,反應介質於60 °C激烈攪拌下加熱5小時 -11 - 本纸張A度適用中國鬮家標率(CNS Μ4^«· ( 210X297公釐) 337833 a? B7 五、發明説明(9 ) 。經冷卻後,加50毫升水接著加5.4毫升濃硫酸至反應介 -質。有機相予以萃取,洗滌,使之乾燥,然後濃縮之。獲 得(4S)- 4 -甲基-4-苯基-2-硫四氫嘍唑_5_酮,產率84 %。 (請先閲讀背面之注意事項再r爲本頁> 裝· 訂 經濟部中央搮準局貝工消費合作社印褽 -12- 本紙張尺度適用中國國家標準(CNS > A4規格(210X297公釐)-Line C 387883 A? ____ B7 V. Description of the invention (8) 2 g (11.1 ¾ ear) (2S) -2-amino-2-phenylpropanoic acid methyl vinegar, 5 ml tetrahydrofuran, 1.82 ml (13 mmol) Mol) triethylamine and 078 ml (13 mmol) carbon disulfide were put into a 25 ml test tube equipped with a magnetic stirrer. After sealing, the test tube was kept at 45 ° C, and the homogeneous medium was continuously stirred at this temperature for 4 hours. After cooling and purification ', 2 g of (4S) _4-methyl_4_phenyl · 2-thiotetrahydropyrazole-5 -one was obtained as a white powder with a yield of 80/0. Actually, H: Preparation of (4S) _. 4 · methyl-4-phenyl-.1-anilino-2-thiohydantoin urea 893 mg (4 pen moles) (4S)-4 -methyl- 4-Phenyl-2-thiotetrahydrou cejun _ 5-one, 8 ml of acetonitrile and 100 ml (0.4 mmol) of tributylamine were input into a 25 ml round-bottomed flask equipped with a magnetizer. . The mixture was warmed up, and then a solution of 520 mg (4.8 mmol) of phenylhydrazine in 4.5 ml of acetonitrile was added for 2 hours. The reaction medium is heated at 80 ° C for 6 hours. After cooling, acetonitrile was removed by distillation under reduced pressure. After purification, 975 mg of (4S) -4-methyl-4 · phenyl-1-anilino-2-thioethyllactone urea was obtained as a white solid with a melting point of 167.0 and a purity of 100 as determined by HPLC. %, That is, a yield of 82%. Example 4: Preparation of (4S) -4-methyl-4-benzyl-2 · thiotetraamine pseling · 11-gram (1) from (2S) -2-amino-2-phenylpropionic acid (1 0.2 mole) (2S) -2-amino-2-phenylpropionic acid (or a mixture containing 15% by weight amino acid in solid NaCl), 10 ml of N-fluorenylpyrrolidone, 0.8 g ( 2. ΗΓ2 mol) sodium hydroxide pellets, followed by 1.8 ml (3. Γ 2 mol) of carbon disulfide, sequentially input into a 50 ml round bottom flask equipped with a magnetic stirrer. After sealing, the reaction medium is heated under intense stirring at 60 ° C for 5 hours. -11-The paper's A degree applies to the Chinese standard (CNS Μ4 ^ «· (210X297 mm) 337833 a? B7. V. Description of the invention ( 9) After cooling, add 50 ml of water and then 5.4 ml of concentrated sulfuric acid to the reaction medium. The organic phase is extracted, washed, dried, and concentrated. (4S) -4 -methyl-4- Phenyl-2-thiotetrahydrooxazole_5_one, yield 84%. (Please read the precautions on the back before r is this page.) -12- This paper size applies to Chinese national standard (CNS > A4 size (210X297 mm)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW86110426A TW387883B (en) | 1997-07-22 | 1997-07-22 | Intermediates for the preparation of 2-imidazolin-5-ones |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW86110426A TW387883B (en) | 1997-07-22 | 1997-07-22 | Intermediates for the preparation of 2-imidazolin-5-ones |
Publications (1)
Publication Number | Publication Date |
---|---|
TW387883B true TW387883B (en) | 2000-04-21 |
Family
ID=21626832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW86110426A TW387883B (en) | 1997-07-22 | 1997-07-22 | Intermediates for the preparation of 2-imidazolin-5-ones |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW387883B (en) |
-
1997
- 1997-07-22 TW TW86110426A patent/TW387883B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2790924C (en) | Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds | |
DK2981519T3 (en) | Process for the preparation of amides from inhibited anilines containing a perhaloalkyl group | |
TW387883B (en) | Intermediates for the preparation of 2-imidazolin-5-ones | |
AU728090B2 (en) | Intermediates for the preparation of 2-imidazoline-5-ones | |
CN108864084B (en) | Apixaban related substances and preparation method thereof | |
JPH05246985A (en) | Method for preparation of bismaleinimide derivative | |
KR20190049883A (en) | Method for producing phenylalanine compound | |
AU746709B2 (en) | Process for the preparation of heteroarylcarboxylic amides and esters | |
CN1934076B (en) | Method for producing semicarbazones | |
CN103702978B (en) | Prepare the cyano group N of 2 amino 5, the method for 3 dimethyl benzamides | |
KR102221534B1 (en) | Process for the synthesis of substituted gamma lactams | |
US6320053B1 (en) | Preparation of heteroarylcarboxamides | |
JP4161290B2 (en) | Process for producing pyrimidinyl alcohol derivatives and synthetic intermediates thereof | |
CA2348374C (en) | Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols | |
US20060035913A1 (en) | Method for the production of 2-amino-4-chloro-6-alkoxypyrimidines | |
EP2855422B1 (en) | Synthesis of diamido gellants by using dane salts of amino acids | |
HUT73774A (en) | Novel phenylethyl and phenyl-propyl-amine, pharmaceutical compns. contg. them and process to prepare the said compds | |
JPS63170353A (en) | Synthesis of aminothioacetamides | |
JPH1036326A (en) | Acid adduct salt of 3-ethynylaniline compound and purification of 3-ethynylaniline compound | |
JP3849155B2 (en) | Process for producing benzobisoxazolone derivatives and intermediates thereof | |
JP3777407B2 (en) | Method for producing carboxylic acid derivative | |
JP2000327652A (en) | Phthalonitrile derivative and its production | |
JPS61180751A (en) | Beta-(acetylamino)acrylic ester | |
JPH1135563A (en) | Production of azol-1-ylalkyl nitrile | |
JPS63165354A (en) | Production of asymmetric cyanhydrin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MK4A | Expiration of patent term of an invention patent |